<i>GGT6</i> as a Prognostic Biomarker and Therapeutic Target in Melanoma Using an Information-theoretical Method.

Although CDC42BPG ( p =0.055) did not reach statistical significance in the Cox model, a trend towards shorter survival was observed in its high-expression group ( n =233; median: 85.08 months; 10-year rate: 38.77%) versus the low-expression group ( n =188; median: 113.50 months; 10-year rate: 48.28%).

also in 111,027 other papers